{"transactions":[{"id":3518410,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-08T20:16:25.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":9092,"price":31.45,"value":285943.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.97  to $31.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares to be issued in connection with the vesting of one or more restricted stock units."}],"balance_after":209004,"source":{"system":"sec-edgar","filing":"0001842979-26-000005","document":"wk-form4_1788898582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842979/000184297926000005/wk-form4_1788898582.xml","form_type":"4"}},{"id":749217,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:16:32.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":2794,"price":22.45,"value":62725.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.03 to $22.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares to be issued in connection with the vesting of one or more restricted stock units."}],"balance_after":218096,"source":{"system":"sec-edgar","filing":"0001842979-26-000003","document":"wk-form4_1780604189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000184297926000003/wk-form4_1780604189.xml","form_type":"4"}},{"id":749216,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:16:32.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":7065,"price":21.74,"value":153593.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $22.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares to be issued in connection with the vesting of one or more restricted stock units."}],"balance_after":220890,"source":{"system":"sec-edgar","filing":"0001842979-26-000003","document":"wk-form4_1780604189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000184297926000003/wk-form4_1780604189.xml","form_type":"4"}},{"id":860741,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:18:17.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":18710,"price":13.39,"value":250526.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":227955,"source":{"system":"sec-edgar","filing":"0001568651-26-000023","document":"wk-form4_1772659095.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865126000023/wk-form4_1772659095.xml","form_type":"4"}},{"id":860740,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2026-03-04T21:18:17.000Z","date":"2026-03-02","kind":"grant","planned":true,"acquired":true,"shares":67424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares to be issued in connection with the vesting of one or more restricted stock units."}],"balance_after":246665,"source":{"system":"sec-edgar","filing":"0001568651-26-000023","document":"wk-form4_1772659095.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865126000023/wk-form4_1772659095.xml","form_type":"4"}},{"id":980006,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-04T21:17:49.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":1852,"price":16.59,"value":30724.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.37 to $16.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":179241,"source":{"system":"sec-edgar","filing":"0001842979-25-000010","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000184297925000010/primarydocument.xml","form_type":"4"}},{"id":1047558,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-04T20:16:19.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1845,"price":16.66,"value":30737.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares to be issued in connection with the vesting of one or more restricted stock units."}],"balance_after":181093,"source":{"system":"sec-edgar","filing":"0001842979-25-000007","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000184297925000007/primarydocument.xml","form_type":"4"}},{"id":1122417,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-04T20:23:54.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1847,"price":13.8,"value":25488.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of Class A common stock withheld by the Issuer to satisfy tax withholding obligations incident to vesting of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares to be issued in connection with the vesting of one or more restricted stock units."}],"balance_after":182938,"source":{"system":"sec-edgar","filing":"0001562180-25-004439","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000156218025004439/primarydocument.xml","form_type":"4"}},{"id":1216882,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-07T21:48:33.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":61409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2025, subject to the reporting person's continuous service through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares to be issued in connection with the vesting of one or more restricted stock units"}],"balance_after":184785,"source":{"system":"sec-edgar","filing":"0001562180-25-002211","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000156218025002211/primarydocument.xml","form_type":"4"}},{"id":1242461,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-02-26T21:21:22.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":185004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest over four years with 25% vesting on March 1, 2026 and the remaining 75% vesting thereafter in 12 equal quarterly installments, subject to the reporting person's continuous service through each vesting date."}],"balance_after":185004,"derivative":{"exercise_price":15.27,"expiration_date":"2035-02-24","underlying":"Class A Common Stock","underlying_shares":185004},"source":{"system":"sec-edgar","filing":"0001562180-25-001684","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000156218025001684/primarydocument.xml","form_type":"4"}},{"id":1242460,"issuer":{"id":3582,"kind":"organization","name":"Oscar Health, Inc.","symbol":"OSCR"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-26T21:21:22.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":123376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares represent restricted stock units, which will vest over four years with 25% vesting on March 1, 2026 and the remaining 75% vesting thereafter in 12 equal quarterly installments, subject to the reporting person's continuous service through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares to be issued in connection with the vesting of one or more restricted stock units"}],"balance_after":123376,"source":{"system":"sec-edgar","filing":"0001562180-25-001684","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1568651/000156218025001684/primarydocument.xml","form_type":"4"}},{"id":1935430,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-29T08:55:32.000Z","date":"2023-03-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":132138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Merger Agreement, each Issuer Option that is not a Cash-Out Option and is outstanding immediately prior to the Effective Time (each, a \"Rollover Stock Option\") was converted into an option to acquire, on substantially the same terms and conditions as were applicable under such Rollover Stock Option, the number of shares of CVS Health Stock (rounded down to the nearest whole share), determined by multiplying (x) the number of shares of Class A Common Stock subject to such Rollover Stock Option immediately prior to the Effective Time by (y) the Exchange Ratio, at an exercise price per share of CVS Health Stock (rounded up to the nearest whole cent) equal to (A) the exercise price per share of Class A Common Stock subject to such Rollover Stock Option divided by (B) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Merger Agreement, each Issuer Option that is not a Cash-Out Option and is outstanding immediately prior to the Effective Time (each, a \"Rollover Stock Option\") was converted into an option to acquire, on substantially the same terms and conditions as were applicable under such Rollover Stock Option, the number of shares of CVS Health Stock (rounded down to the nearest whole share), determined by multiplying (x) the number of shares of Class A Common Stock subject to such Rollover Stock Option immediately prior to the Effective Time by (y) the Exchange Ratio, at an exercise price per share of CVS Health Stock (rounded up to the nearest whole cent) equal to (A) the exercise price per share of Class A Common Stock subject to such Rollover Stock Option divided by (B) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to the Merger Agreement, each Issuer Option that is not a Cash-Out Option and is outstanding immediately prior to the Effective Time (each, a \"Rollover Stock Option\") was converted into an option to acquire, on substantially the same terms and conditions as were applicable under such Rollover Stock Option, the number of shares of CVS Health Stock (rounded down to the nearest whole share), determined by multiplying (x) the number of shares of Class A Common Stock subject to such Rollover Stock Option immediately prior to the Effective Time by (y) the Exchange Ratio, at an exercise price per share of CVS Health Stock (rounded up to the nearest whole cent) equal to (A) the exercise price per share of Class A Common Stock subject to such Rollover Stock Option divided by (B) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":14.19,"underlying":"Class A Common Stock","underlying_shares":132138},"source":{"system":"sec-edgar","filing":"0000899243-23-009936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000089924323009936/doc4.xml","form_type":"4"}},{"id":1935429,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-29T08:55:32.000Z","date":"2023-03-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":213556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":8.46,"underlying":"Class A Common Stock","underlying_shares":213556},"source":{"system":"sec-edgar","filing":"0000899243-23-009936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000089924323009936/doc4.xml","form_type":"4"}},{"id":1935428,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-29T08:55:32.000Z","date":"2023-03-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Pursuant to the Merger Agreement, each Issuer Option that is not a Cash-Out Option and is outstanding immediately prior to the Effective Time (each, a \"Rollover Stock Option\") was converted into an option to acquire, on substantially the same terms and conditions as were applicable under such Rollover Stock Option, the number of shares of CVS Health Stock (rounded down to the nearest whole share), determined by multiplying (x) the number of shares of Class A Common Stock subject to such Rollover Stock Option immediately prior to the Effective Time by (y) the Exchange Ratio, at an exercise price per share of CVS Health Stock (rounded up to the nearest whole cent) equal to (A) the exercise price per share of Class A Common Stock subject to such Rollover Stock Option divided by (B) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Merger Agreement, each Issuer Option that is not a Cash-Out Option and is outstanding immediately prior to the Effective Time (each, a \"Rollover Stock Option\") was converted into an option to acquire, on substantially the same terms and conditions as were applicable under such Rollover Stock Option, the number of shares of CVS Health Stock (rounded down to the nearest whole share), determined by multiplying (x) the number of shares of Class A Common Stock subject to such Rollover Stock Option immediately prior to the Effective Time by (y) the Exchange Ratio, at an exercise price per share of CVS Health Stock (rounded up to the nearest whole cent) equal to (A) the exercise price per share of Class A Common Stock subject to such Rollover Stock Option divided by (B) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Pursuant to the Merger Agreement, each option to purchase a share of Class A Common Stock (each, an \"Issuer Option\") granted by Issuer under an Issuer stock plan that was (i) outstanding as of immediately prior to the Effective Time and was vested and unexercised (but not, for the avoidance of doubt, (x) any unvested Issuer Option that was outstanding immediately prior to the Effective Time with an exercise price that is equal to or greater than $30.50 or (y) any Issuer Option that is forfeited due to failure to satisfy performance-based conditions) or (ii) outstanding immediately prior to the Effective Time and was held by a non-employee director, consultant or independent contractor of the Issuer (whether vested or unvested) (each, a \"Cash-Out Option\"), was cancelled and converted into the right to receive an amount in cash equal to the product of (1) the excess, if any, of the Per Share Consideration over the per-share exercise price of such Cash-Out Option, multiplied by"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"(Continued from Footnote 6) (2) the number of shares of Class A Common Stock then subject to such Cash-Out Option as of immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Pursuant to the Merger Agreement, each Issuer Option that is not a Cash-Out Option and is outstanding immediately prior to the Effective Time (each, a \"Rollover Stock Option\") was converted into an option to acquire, on substantially the same terms and conditions as were applicable under such Rollover Stock Option, the number of shares of CVS Health Stock (rounded down to the nearest whole share), determined by multiplying (x) the number of shares of Class A Common Stock subject to such Rollover Stock Option immediately prior to the Effective Time by (y) the Exchange Ratio, at an exercise price per share of CVS Health Stock (rounded up to the nearest whole cent) equal to (A) the exercise price per share of Class A Common Stock subject to such Rollover Stock Option divided by (B) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":24,"underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-23-009936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000089924323009936/doc4.xml","form_type":"4"}},{"id":1935427,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"LLC Units in Cure Aggregator, LLC","published_at":"2023-03-29T08:55:32.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":false,"shares":24173,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. (\"Parent\") and Noah Merger Sub, Inc. (the \"Merger Agreement\"), the Reporting Person received 24,173 shares of the Issuer's Class A Common Stock (\"Class A Common Stock\") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC (\"LLC Units\") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock (\"Class B Common Stock\")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. (\"Parent\") and Noah Merger Sub, Inc. (the \"Merger Agreement\"), the Reporting Person received 24,173 shares of the Issuer's Class A Common Stock (\"Class A Common Stock\") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC (\"LLC Units\") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock (\"Class B Common Stock\")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. (\"Parent\") and Noah Merger Sub, Inc. (the \"Merger Agreement\"), the Reporting Person received 24,173 shares of the Issuer's Class A Common Stock (\"Class A Common Stock\") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC (\"LLC Units\") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock (\"Class B Common Stock\")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. (\"Parent\") and Noah Merger Sub, Inc. (the \"Merger Agreement\"), the Reporting Person received 24,173 shares of the Issuer's Class A Common Stock (\"Class A Common Stock\") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC (\"LLC Units\") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock (\"Class B Common Stock\")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":24173},"source":{"system":"sec-edgar","filing":"0000899243-23-009936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000089924323009936/doc4.xml","form_type":"4"}},{"id":1935426,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2023-03-29T08:55:32.000Z","date":"2023-03-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":69062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each share of Class A Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled and converted into the right to receive the Per Share Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-009936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000089924323009936/doc4.xml","form_type":"4"}},{"id":1935425,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class B Common Stock","published_at":"2023-03-29T08:55:32.000Z","date":"2023-03-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24173,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, each share of Class B Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each share of Class B Common Stock outstanding and held by the Reporting Person immediately prior to the Effective Time, was cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-009936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000089924323009936/doc4.xml","form_type":"4"}},{"id":1935424,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2023-03-29T08:55:32.000Z","date":"2023-03-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":85137,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, as of the effective time of the merger (the \"Effective Time\"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an \"Issuer RSU\") that was not (i) outstanding immediately prior to the Effective Time to the extent vested and unsettled or (ii) outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer and was outstanding immediately prior to the Effective Time (each, a \"Rollover RSU\") was converted into a restricted stock unit, subject to substantially the same terms and conditions as were applicable under such Rollover RSU, with respect to a number of shares of common stock of CVS Health Corporation (\"CVS Health Stock\") equal to the number of shares of Class A Common Stock subject to such Rollover RSU multiplied by a fraction,"},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from Footnote 2) the numerator of which is the Per Share Consideration and the denominator of which is the volume weighted average trading price (rounded to the nearest $0.01) of one share of CVS Health Stock on the New York Stock Exchange as reported on Bloomberg L.P. under the function \"VWAP\" (or, if not reported therein, in another authoritative source mutually selected by the parties) for the ten (10) consecutive trading days ending on (and including) the trading day that is three (3) trading days prior to the date of the closing of the Merger (the \"Exchange Ratio\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, as of the effective time of the merger (the \"Effective Time\"), each restricted stock unit with respect to shares of the Issuer's Class A Common Stock (each, an \"Issuer RSU\") that was not (i) outstanding immediately prior to the Effective Time to the extent vested and unsettled or (ii) outstanding immediately prior to the Effective Time and was held by any person who is a non-employee director, consultant or independent contractor engaged by the Issuer and was outstanding immediately prior to the Effective Time (each, a \"Rollover RSU\") was converted into a restricted stock unit, subject to substantially the same terms and conditions as were applicable under such Rollover RSU, with respect to a number of shares of common stock of CVS Health Corporation (\"CVS Health Stock\") equal to the number of shares of Class A Common Stock subject to such Rollover RSU multiplied by a fraction,"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) the numerator of which is the Per Share Consideration and the denominator of which is the volume weighted average trading price (rounded to the nearest $0.01) of one share of CVS Health Stock on the New York Stock Exchange as reported on Bloomberg L.P. under the function \"VWAP\" (or, if not reported therein, in another authoritative source mutually selected by the parties) for the ten (10) consecutive trading days ending on (and including) the trading day that is three (3) trading days prior to the date of the closing of the Merger (the \"Exchange Ratio\")."}],"balance_after":69062,"source":{"system":"sec-edgar","filing":"0000899243-23-009936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000089924323009936/doc4.xml","form_type":"4"}},{"id":1935423,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2023-03-29T08:55:32.000Z","date":"2023-03-29","kind":"exercise","planned":false,"acquired":true,"shares":24173,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. (\"Parent\") and Noah Merger Sub, Inc. (the \"Merger Agreement\"), the Reporting Person received 24,173 shares of the Issuer's Class A Common Stock (\"Class A Common Stock\") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC (\"LLC Units\") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock (\"Class B Common Stock\")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 29, 2023, pursuant to that certain Agreement and Plan of Merger, dated September 2, 2022, between the Issuer, CVS Pharmacy, Inc. (\"Parent\") and Noah Merger Sub, Inc. (the \"Merger Agreement\"), the Reporting Person received 24,173 shares of the Issuer's Class A Common Stock (\"Class A Common Stock\") pursuant to the exchange by Cure Aggregator, LLC of LLC Units of Cure TopCo, LLC (\"LLC Units\") for the Issuer's Class A Common Stock on a one-for one basis (and the corresponding cancellation of an equal number of shares of the Issuer's Class B Common Stock (\"Class B Common Stock\")), and the subsequent distribution by Cure Aggregator, LLC to the Reporting Person of such shares of Class A Common Stock."}],"balance_after":154199,"source":{"system":"sec-edgar","filing":"0000899243-23-009936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000089924323009936/doc4.xml","form_type":"4"}},{"id":1960385,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2023-03-09T16:06:51.000Z","date":"2023-03-07","kind":"tax_withholding","acquired":false,"shares":3750,"price":28.37,"value":106387.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of RSUs granted on March 7, 2022."}],"balance_after":130026,"source":{"system":"sec-edgar","filing":"0000950103-23-003901","document":"dp190408_4-mcananey.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010323003901/dp190408_4-mcananey.xml","form_type":"4"}},{"id":1982809,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2023-03-01T17:23:12.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":52102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units on February 27, 2023 that will vest in equal annual installments on each of the first four anniversaries of the grant date."}],"balance_after":133776,"source":{"system":"sec-edgar","filing":"0000950103-23-003477","document":"dp189943_4-mcananey.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010323003477/dp189943_4-mcananey.xml","form_type":"4"}},{"id":2340965,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-09T18:02:22.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":132138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest in equal annual installments on each of the first four anniversaries of the March 7, 2022 grant date."}],"balance_after":132138,"derivative":{"exercise_price":14.19,"expiration_date":"2032-03-07","underlying":"Class A Common Stock","underlying_shares":132138},"source":{"system":"sec-edgar","filing":"0000950103-22-004329","document":"dp168894_4-mcananey.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010322004329/dp168894_4-mcananey.xml","form_type":"4"}},{"id":2340964,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2022-03-09T18:02:22.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":44046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units on March 7, 2022 that will vest in equal annual installments on each of the first four anniversaries of the grant date."}],"balance_after":81674,"source":{"system":"sec-edgar","filing":"0000950103-22-004329","document":"dp168894_4-mcananey.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010322004329/dp168894_4-mcananey.xml","form_type":"4"}},{"id":2853106,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"LLC Units in Cure Aggregator, LLC","published_at":"2021-02-17T20:05:23.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":24173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The LLC Units service-vest 25% on each of the first four anniversaries of November 27, 2019 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire."},{"field":"shares","element":"transactionShares","label":"F2","text":"These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The LLC Units service-vest 25% on each of the first four anniversaries of November 27, 2019 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The LLC Units service-vest 25% on each of the first four anniversaries of November 27, 2019 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F5","text":"The LLC Units service-vest 25% on each of the first four anniversaries of November 27, 2019 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire."}],"balance_after":24173,"derivative":{"underlying":"Class A Common Stock","underlying_shares":24173},"source":{"system":"sec-edgar","filing":"0000950103-21-002449","document":"dp146248_4-mcananey.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010321002449/dp146248_4-mcananey.xml","form_type":"4"}},{"id":2853105,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-17T20:05:23.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":213556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in New Remedy Corp."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options service-vest in equal installments on each of June 10, 2021, 2022 and 2023 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified multiple of invested capital return thresholds."}],"balance_after":213556,"derivative":{"exercise_price":8.46,"expiration_date":"2029-06-10","underlying":"Class A Common Stock","underlying_shares":213556},"source":{"system":"sec-edgar","filing":"0000950103-21-002449","document":"dp146248_4-mcananey.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010321002449/dp146248_4-mcananey.xml","form_type":"4"}},{"id":2853104,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2021-02-17T20:05:23.000Z","date":"2021-02-16","kind":"purchase","acquired":true,"shares":13900,"price":24,"value":333600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These securities were purchased through the Issuer's directed share program in connection with its initial public offering."}],"balance_after":37628,"source":{"system":"sec-edgar","filing":"0000950103-21-002449","document":"dp146248_4-mcananey.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010321002449/dp146248_4-mcananey.xml","form_type":"4"}},{"id":2853103,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class B Common Stock","published_at":"2021-02-17T20:05:23.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":24173,"price":0.01,"value":241.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC."}],"balance_after":24173,"source":{"system":"sec-edgar","filing":"0000950103-21-002449","document":"dp146248_4-mcananey.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010321002449/dp146248_4-mcananey.xml","form_type":"4"}},{"id":2853102,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Class A Common Stock","published_at":"2021-02-17T20:05:23.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":23728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in New Remedy Corp."}],"balance_after":23728,"source":{"system":"sec-edgar","filing":"0000950103-21-002449","document":"dp146248_4-mcananey.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010321002449/dp146248_4-mcananey.xml","form_type":"4"}},{"id":2862063,"issuer":{"id":114996,"kind":"organization","name":"Signify Health, Inc.","symbol":"SGFY"},"owners":[{"id":41242,"kind":"person","name":"McAnaney Adam","position":1,"cik":"0001842979","reported_name":"McAnaney Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Options (right to buy)","published_at":"2021-02-12T16:50:44.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in equal annual installments on each of the first three anniversaries of the February 10, 2021 grant date."}],"balance_after":50000,"derivative":{"exercise_price":24,"expiration_date":"2031-02-10","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950103-21-002273","document":"dp145999_4-mcananey.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1828182/000095010321002273/dp145999_4-mcananey.xml","form_type":"4"}}]}